Hikma Pharmaceuticals PLC (HIK.L)
HIK.L Stock Price Chart
Explore Hikma Pharmaceuticals PLC interactive price chart. Choose custom timeframes to analyze HIK.L price movements and trends.
HIK.L Company Profile
Discover essential business fundamentals and corporate details for Hikma Pharmaceuticals PLC (HIK.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1 Nov 2005
Employees
9.50K
Website
https://www.hikma.comCEO
Riad Ali Mishlawi
Description
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
HIK.L Financial Timeline
Browse a chronological timeline of Hikma Pharmaceuticals PLC corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 7 Aug 2025
Dividend declared on 20 Mar 2025
A dividend of £28.85 per share was announced, adjusted to £28.85. The dividend was paid on 1 May 2025.
Earnings released on 26 Feb 2025
EPS came in at £0.48, while revenue for the quarter reached £1.24B, beating expectations by +1.94%.
Dividend declared on 15 Aug 2024
A dividend of £24.74 per share was announced, adjusted to £24.74. The dividend was paid on 20 Sept 2024.
Earnings released on 8 Aug 2024
EPS came in at £0.80, while revenue for the quarter reached £1.24B, beating expectations by +4.41%.
Earnings released on 25 Apr 2024
EPS came in at £0.21 falling short of the estimated £0.75 by -72.20%, while revenue for the quarter reached £1.15B, beating expectations by +6.38%.
Dividend declared on 21 Mar 2024
A dividend of £37.19 per share was announced, adjusted to £37.19. The dividend was paid on 3 May 2024.
Dividend declared on 10 Aug 2023
A dividend of £15.66 per share was announced, adjusted to £15.66. The dividend was paid on 15 Sept 2023.
Earnings released on 3 Aug 2023
EPS came in at £0.47 falling short of the estimated £0.75 by -37.73%, while revenue for the quarter reached £1.13B, beating expectations by +7.35%.
Earnings released on 23 Feb 2023
EPS came in at £0.06 falling short of the estimated £0.65 by -91.45%, while revenue for the quarter reached £1.06B, beating expectations by +3.38%.
Dividend declared on 23 Feb 2023
A dividend of £24.08 per share was announced, adjusted to £24.08. The dividend was paid on 5 May 2023.
Dividend declared on 4 Aug 2022
A dividend of £16.00 per share was announced, adjusted to £13.41. The dividend was paid on 20 Sept 2022.
Earnings released on 30 Jun 2022
EPS came in at £0.63 falling short of the estimated £0.76 by -18.19%, while revenue for the quarter reached £999.12M, missing expectations by -0.19%.
Dividend declared on 24 Feb 2022
A dividend of £19.79 per share was announced, adjusted to £19.79. The dividend was paid on 28 Apr 2022.
Earnings released on 31 Dec 2021
EPS came in at £0.55 falling short of the estimated £0.72 by -23.68%, while revenue for the quarter reached £991.09M, beating expectations by +4.94%.
Dividend declared on 6 Aug 2021
A dividend of £9.50 per share was announced, adjusted to £9.50. The dividend was paid on 20 Sept 2021.
Earnings released on 30 Jun 2021
EPS came in at £0.77 surpassing the estimated £0.65 by +18.89%, while revenue for the quarter reached £880.32M, beating expectations by +0.31%.
Dividend declared on 25 Feb 2021
A dividend of £17.77 per share was announced, adjusted to £17.77. The dividend was paid on 26 Apr 2021.
Earnings released on 31 Dec 2020
EPS came in at £0.69 surpassing the estimated £0.64 by +8.49%, while revenue for the quarter reached £888.02M, missing expectations by -0.02%.
Dividend declared on 7 Aug 2020
A dividend of £9.12 per share was announced, adjusted to £9.12. The dividend was paid on 21 Sept 2020.
HIK.L Stock Performance
Access detailed HIK.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.